PubRank

Gian Paolo Rossi

Author PubWeight™ 71.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005 2.46
2 Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005 2.12
3 Biological properties of the angiotensin peptides other than angiotensin II: implications for hypertension and cardiovascular diseases. J Hypertens 2002 1.65
4 Munchausen syndrome: a novel cause of drug-resistant hypertension. J Hypertens 2013 1.63
5 Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols. Hypertension 2009 1.57
6 Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER Project. J Hypertens 2003 1.52
7 Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course. Endocr Relat Cancer 2005 1.20
8 Primary hyperparathyroidism with concurrent primary aldosteronism. Hypertension 2011 1.16
9 The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. Mediators Inflamm 2013 1.15
10 Aldosterone-induced oxidative stress: a potential mechanism of aldosterone autonomy in primary aldosteronism. J Hypertens 2014 1.10
11 Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis. Hypertension 2007 1.04
12 Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II. J Am Coll Cardiol 2003 1.02
13 A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium. J Clin Endocrinol Metab 2014 1.02
14 Heritability of plasma adiponectin levels and body mass index in twins. J Clin Endocrinol Metab 2007 0.99
15 Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol Rev 2006 0.96
16 Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma. Hypertension 2012 0.96
17 Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts. Am J Hypertens 2007 0.94
18 Decongestion in acute heart failure. Eur J Heart Fail 2014 0.94
19 Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives. Arterioscler Thromb Vasc Biol 2004 0.92
20 Unilateral adrenal hyperplasia: a novel cause of surgically correctable primary hyperaldosteronism. Surgery 2012 0.92
21 The role of adrenal venous sampling in the surgical management of primary aldosteronism. World J Surg 2006 0.89
22 Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients. J Clin Endocrinol Metab 2008 0.89
23 Impact of accessory hepatic veins on adrenal vein sampling for identification of surgically curable primary aldosteronism. Hypertension 2009 0.89
24 Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: Evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells. FEBS Lett 2003 0.88
25 Ultrafiltration in heart failure with cardiorenal syndrome. N Engl J Med 2013 0.87
26 GPER-1 and estrogen receptor-β ligands modulate aldosterone synthesis. Endocrinology 2014 0.87
27 Lower expression of the TWIK-related acid-sensitive K+ channel 2 (TASK-2) gene is a hallmark of aldosterone-producing adenoma causing human primary aldosteronism. J Clin Endocrinol Metab 2013 0.87
28 Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol 2004 0.85
29 Glycolytic enzyme expression and pyruvate kinase activity in cultured fibroblasts from type 1 diabetic patients with and without nephropathy. Biochim Biophys Acta 2008 0.84
30 A diagnostic algorithm--the holy grail of primary aldosteronism. Nat Rev Endocrinol 2011 0.84
31 The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension. J Hypertens 2006 0.83
32 Role of angiotensin II, endothelin-1 and L-type calcium channel in the development of glomerular, tubulointerstitial and perivascular fibrosis. J Hypertens 2008 0.83
33 Cardiac consequences of aldosterone excess in human hypertension. Am J Hypertens 2006 0.83
34 Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro. Int J Mol Med 2006 0.83
35 Bradykinin and matrix metalloproteinases are involved the structural alterations of rat small resistance arteries with inhibition of ACE and NEP. J Hypertens 2004 0.83
36 Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension. Clin Chem Lab Med 2016 0.82
37 Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients. PLoS One 2012 0.82
38 Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling. J Clin Endocrinol Metab 2012 0.81
39 A twin study of heritability of plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) mass and activity. Atherosclerosis 2008 0.81
40 Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter's and Gitelman's syndromes, human models of endogenous angiotensin II signaling antagonism. J Hypertens 2014 0.81
41 Systolic and diastolic short-term blood pressure variability and its determinants in patients with controlled and uncontrolled hypertension: a retrospective cohort study. Blood Press 2015 0.81
42 Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients. J Hypertens 2014 0.80
43 Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens 2009 0.80
44 Exon 11 deletion in the myocyte enhancer factor (MEF)2A and early onset coronary artery disease gene in a Sicilian family. Eur J Cardiovasc Prev Rehabil 2011 0.80
45 Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients. Int J Cardiol 2012 0.79
46 Urotensin-II and UII-receptor expression and function in the rat adrenal cortex. Int J Mol Med 2006 0.79
47 Identification of the mineralocorticoid receptor in human spermatozoa. Int J Mol Med 2006 0.78
48 Lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms and cardiovascular events in patients with coronary artery disease. J Cardiovasc Med (Hagerstown) 2015 0.78
49 PLCβ1-SHP-2 complex, PLCβ1 tyrosine dephosphorylation and SHP-2 phosphatase activity: a new part of Angiotensin II signaling? J Biomed Sci 2011 0.78
50 Obstructive sleep apnea, gestational hypertension and preeclampsia: a review of the literature. Curr Opin Pulm Med 2014 0.78
51 Isolation of human adrenocortical aldosterone-producing cells by a novel immunomagnetic beads method. Endocrinology 2010 0.78
52 Expression and functional role of the prorenin receptor in the human adrenocortical zona glomerulosa and in primary aldosteronism. J Hypertens 2015 0.78
53 Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients. J Hypertens 2014 0.77
54 Endothelial nitric oxide synthase gene polymorphisms and renal survival. Hypertension 2003 0.77
55 Caldesmon over-expression in type 1 diabetic nephropathy. J Diabetes Complications 2010 0.77
56 Up-regulation of the adrenomedullin system mediates hypotension and hypoaldosteronism induced by simulated microgravity. Int J Mol Med 2004 0.77
57 Do meta-analyses of association studies of endothelial nitric oxide synthase variants and ischemic heart disease provide conclusive answers? Circulation 2004 0.77
58 Expression and functional role of urotensin-II and its receptor in the adrenal cortex and medulla: novel insights for the pathophysiology of primary aldosteronism. J Clin Endocrinol Metab 2008 0.77
59 Apparent mineralcorticoid excess syndrome, an often forgotten or unrecognized cause of hypokalemia and hypertension: case report and appraisal of the pathophysiology. Blood Press 2013 0.76
60 Outcome of surgical treatment of primary aldosteronism. Langenbecks Arch Surg 2015 0.76
61 More fuel to the debate on the "epidemics of primary aldosteronism". Hypertension 2007 0.76
62 Under treatment with lipid-lowering drugs of high-risk coronary heart disease patients of the GENICA study. J Cardiovasc Pharmacol 2003 0.76
63 A stress reaction affects assessment of selectivity of adrenal venous sampling and of lateralization of aldosterone excess in primary aldosteronism. Eur J Endocrinol 2012 0.76
64 Identification and localization of adrenomedullin-storing cardiac mast cells. Int J Mol Med 2006 0.76
65 Is homocysteine important as risk factor for coronary heart disease? Nutr Metab Cardiovasc Dis 2005 0.76
66 Adrenomedullin, ANP and BNP are colocalized in a subset of endocrine cells in the rat heart. Int J Mol Med 2005 0.76
67 Adrenal venous sampling but not computed tomography is essential before undertaking adrenalectomy for primary aldosteronism. Surgery 2011 0.76
68 Mechanisms transducing the aldosterone secretagogue signal of endothelins in the human adrenal cortex. Peptides 2002 0.76
69 Arginine vasopressin receptor antagonists for heart failure: a winter climbing to the Everest's tip? J Am Coll Cardiol 2007 0.75
70 Sildenafil in idiopathic pulmonary fibrosis. N Engl J Med 2010 0.75
71 Therapy: raising HDL cholesterol levels: a flight of Icarus? Nat Rev Endocrinol 2010 0.75
72 Adiponectin and prognostic outcome in patients with coronary artery disease. Eur Heart J 2008 0.75
73 Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure. Circulation 2003 0.75
74 Response to implementation of rapid cortisol during adrenal vein sampling. Hypertension 2014 0.75
75 T-786C and G894T variants of the endothelial nitric oxide synthase gene and training-induced correction of endothelial dysfunction in coronary artery disease patient. Arterioscler Thromb Vasc Biol 2004 0.75
76 Response to Effectiveness of adrenalectomy and aldosterone antagonists for long-term treatment of primary aldosteronism. Hypertension 2013 0.75
77 Losartan metabolite EXP3179: an AT1-receptor-independent treatment strategy for patients with the metabolic syndrome? Hypertension 2009 0.75
78 Left ventricular changes in primary aldosteronism. Am J Hypertens 2003 0.75
79 Lowering homocysteine with B vitamins in patients with coronary artery disease. JAMA 2008 0.75
80 Oral Burning With Dysphagia and Weight Loss. Medicine (Baltimore) 2015 0.75
81 Antiplatelets treatment in atherosclerotic renal artery stenosis: need of consensus-based recommendations. J Hypertens 2011 0.75
82 Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism. J Hypertens 2016 0.75
83 The subtyping of primary aldosteronism by adrenal vein sampling: sequential blood sampling causes factitious lateralization. J Hypertens 2017 0.75
84 Catheter-related atrial thrombosis in a patient with recent cerebral haemorrhage: to treat or not to treat? Intern Emerg Med 2010 0.75
85 Chromogranin a measurement for assessing the selectivity of adrenal venous sampling in primary aldosteronism. J Clin Endocrinol Metab 2011 0.75
86 Pelvic-ureteric junction obstruction and hypertension with target organ damage: a case report and review of the literature. Blood Press 2013 0.75
87 Revascularization for atherosclerotic renal artery stenosis: another flawed son of the ASTRAL Study. Hypertens Res 2012 0.75
88 Autocrine-Paracrine Role of Endothelin-1 in the Regulation of Aldosterone Synthase Expression and Intracellular Ca2+ in Human Adrenocortical Carcinoma NCI-H295 Cells. Endocrinology 1997 0.75
89 Aldosterone and renin in cardiac patients referred for catheterization. Medicine (Baltimore) 2017 0.75
90 OS 35-09 LONG-TERM OUTCOME OF SURGICALLY- AND MEDICALLY-TREATED PATIENTS OF THE PRIMARY ALDOSTERONISM PREVALENCE IN HYPERTENSIVES (PAPY) STUDY. J Hypertens 2016 0.75
91 Obituary: Cesare Dal Palù MD 20-01-1923-18-01-2016. J Hypertens 2016 0.75
92 Subtyping of primary aldosteronism by adrenal vein sampling: effect of acute D(2) receptor dopaminergic blockade on adrenal vein cortisol and chromogranin A levels. Eur J Endocrinol 2011 0.75
93 OS 35-09 LONG-TERM OUTCOME OF SURGICALLY- AND MEDICALLY-TREATED PATIENTS OF THE PRIMARY ALDOSTERONISM PREVALENCE IN HYPERTENSIVES (PAPY) STUDY. J Hypertens 2016 0.75
94 Expression of telomerase (hTERT) in aldosterone-producing adrenocortical tumors. Int J Mol Med 2006 0.75
95 Mobility timing for agent communities, a cue for advanced connectionist systems. IEEE Trans Neural Netw 2011 0.75
96 Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders. J Hypertens 2016 0.75
97 Uncontrolled hypertension: highlights and perspectives from the European Society of Hypertension Satellite Symposium. Expert Rev Cardiovasc Ther 2011 0.75
98 Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension. Crit Rev Clin Lab Sci 2005 0.75